Emerald Medical Application

Company Overview

Snapshot

Founded in February 2010 by Lior Wayn, Emerald Medical Application operates with 1–10 employees. The company has raised $1.55M across two funding rounds, with Kodiak Capital Group, LLC participating. In May 2016, the company secured an equity purchase agreement with Kodiak Capital Group, LLC.

Business overview

Emerald Medical Application develops technology that leverages military image processing and big-data analytics to enhance the analysis of medical images. Its core product, DermaCompare, is a Class 1, FDA-approved, HIPAA-compliant skin cancer screening platform. This platform enables physicians to identify and monitor changes in patients' skin health for the early detection of skin cancers and other anomalies. The company serves the healthcare industry, operating within the Health Tech & Life Sciences sector, specifically focusing on digital healthcare and digital medical diagnostics.

Strategic signal

In November 2016, Emerald Medical Application's DermaCompare technology was selected as one of four startup technology winners in Merck's Health Innovation Technology Scouts (HITS) Program. This recognition signals strong industry validation for their image processing and big-data analytics approach to medical diagnostics, highlighting its potential to impact early skin cancer detection and improve patient outcomes.

Company Intelligence Q&A

What is DermaCompare?

DermaCompare is Emerald Medical Application's Class 1, FDA-approved, HIPAA-compliant skin cancer screening platform. It uses military image processing and big-data analytics to help physicians identify and monitor changes in patients' skin for early detection of skin cancers and other anomalies.

When was Emerald Medical Application founded?

Emerald Medical Application was founded in February 2010 by Lior Wayn.

Which investor participated in a funding round for Emerald Medical Application?

In May 2016, Emerald Medical Application secured an equity purchase agreement with Kodiak Capital Group, LLC.

What recognition did DermaCompare receive in 2016?

In November 2016, Emerald Medical Application's DermaCompare technology was chosen as one of four startup technology winners of Merck's Health Innovation Technology Scouts (HITS) Program.

How does the DermaCompare patient application function?

The DermaCompare patient application, available on iOS and Android, allows patients to use their mobile device's digital camera to take and transmit Total Body Photography images for dermatological evaluation. These images are then analyzed using Emerald Medical Application's cloud database and previous patient images to enhance early detection of melanoma.